51 The current study reveals one more link between the immune and

51 The current study reveals one more link between the immune and neuroendocrine systems in which the neuroendocrine AMP catestatin activates human mast cells, and may exert immunomodulatory effects on the cutaneous immune system. Further studies are needed for investigation of the pathophysiological roles of catestatin peptides in tissues where mast cells are abundantly SB203580 present. Our sincere thanks go to Dr Arnold Kirshenbaum (National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD) for kindly providing the LAD2 cell line. We thank the members of the Atopy (Allergy) Research Center and the Department of Immunology of Juntendo

University School of Medicine for their encouragement and critical comments, and Ms Michiyo Matsumoto for secretarial Akt tumor assistance. We are also deeply indebted to Dr Mukesh Pasupuleti (University of British Columbia, Vancouver, Canada)

for his contribution in designing the catestatin scrambled peptide. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Atopy (Allergy) Research Center, Juntendo University, Tokyo, Japan; and Japan International Cooperation Agency (JICA). The authors have no conflicts of interest to declare. “
“Several epidemiological studies have demonstrated that patients with primary biliary cirrhosis (PBC) have a higher incidence of urinary tract infections (UTI) and there is significant homology of the immunodominant mitochondrial autoantigen, the E2 component of the pyruvate dehydrogenase complex (PDC-E2), between mammals and bacteria. Previous work

has demonstrated that non-obese diabetic (NOD).B6 Idd10/Idd18 infected with Novosphingobium aromaticivorans developed liver lesions similar to human PBC. It was postulated Endonuclease that the biliary disease was dependent upon the presence of the unique N. aro glycosphingolipids in activating natural killer T (NK T) cells. To address this issue, we infected NOD.B6 Idd10/Idd18 mice with either Escherichia coli, N. aro or use of a phosphate-buffered saline (PBS) vehicle control and serially followed animals for the appearance of liver pathology and anti-mitochondrial autoantibodies (AMA). Of striking importance, the biliary disease of E. coli-infected mice was more severe than N. Aro-infected mice and the titre of AMA was higher in E. coli-infected mice. Furthermore, the immunopathology did not correlate with the ability of bacterial extracts to produce antigen-dependent activation of NK T cells. Our data suggest that the unique glycosphingolipids of N. aro are not required for the development of autoimmune cholangitis. Importantly, the data highlight the clinical significance of E.

Comments are closed.